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Delayed Enhancement
Abnormalities as a Substrate
for Persistent Atrial Fibrillation
Bright Horizons or White Noise?*
Sanjay Dixit, MD, Jeffrey S. Arkles, MD
Philadelphia, Pennsylvania
It has been posited that persistent atrial ﬁbrillation (AF) is
maintained by the underlying substrate rather than triggers
alone (1). This has resulted in the use of adjunctive
substrate-modifying ablation strategies for this group of
patients. These include, in addition to antral pulmonary
vein isolation (PVI), ablation of complex fractionated
electrograms (CFEs), creating a linear lesion across poten-
tial re-entrant channels, and targeting ganglionated plexi/
AF nests (2). However, none of these adjunctive strategies
have yielded consistent results. For this reason perhaps,
there is renewed interest in better understanding the nature
of the substrate that may underlie persistent forms of AF. ItSee page 802is well recognized that as AF progresses (from the parox-
ysmal stage to the persistent stage), there is associated atrial
enlargement. Histopathological analysis of atrial tissue ob-
tained from patients with AF undergoing open-heart
surgery has shown a signiﬁcant increase in extracellular
matrix and ﬁbrosis (3). Innovations in cardiac magnetic
resonance (CMR) techniques, especially gadolinium-based
delayed enhancement (DE) imaging, have advanced our
ability to accurately identify ﬁbrosis in the ventricular
myocardium (4). More recently, using a novel imaging
technique, Oakes et al. (5) showed the presence of DE
abnormalities consistent with left atrial (LA) ﬁbrosis in
patients with paroxysmal and persistent AF. When present,
LA scar was an independent adverse prognosticator of long-
term success of an AF ablation procedure in this series.
However, the mechanism(s) underlying this association was
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by Jadidi et al. (6) in this issue of the Journal attempts to
address this lacuna by providing insights on how atrial
ﬁbrosis may inﬂuence electrogram (EGM) recordings
during human AF.
In this case series comprised of 18 patients with persis-
tent (n ¼ 7) and long-standing persistent (n ¼ 11) AF, the
investigators performed DE magnetic resonance (MR)
imaging using the same protocol as described by Oakes
et al. (5). MR images were processed to identify DE
abnormalities that were regionally categorized as dense
(>90% distribution), patchy (20% to 70% distribution), or
normal (no DE). These patients subsequently underwent
AF ablation at which time, a detailed electroanatomic (EA)
shell of LA was constructed using a 20-pole catheter. After
merging the EA shell with MR segmented LA anatomy,
electrogram (EGM) recordings were analyzed for CFE
content/organization and its distribution vis-à-vis areas
manifesting dense, patchy, or no DE. The investigators
found that dense DE was less frequently observed in these
patients, and when present, it was usually seen in the
posterior left atrium adjoining the left pulmonary veins
(PVs). In contrast, patchy DE was more frequent, and this
too was typically observed in the posterior LA but more
commonly around the right PVs. The overall DE content
(mostly of patchy type) was higher in patients with long-
standing persistent versus persistent AF. CFE distribution
also yielded some interesting information. Although CFEs
were widespread, continuous CFE recordings (which the
investigators implicate as being critical to AF maintenance)
were seen mostly at sites manifesting patchy or no DE
abnormalities. In contrast, dense DE regions typically
manifested more organized and slower EGM recordings in
the majority (78%). Only rarely (19%) were continuous
CFE recordings seen at the border of dense DE regions.
Although DE sites were not speciﬁcally targeted as a part of
the ablation strategy in this series, the investigators observed
prolongation of AF cycle length (in the LA appendage)
after PVI and stepwise regional ablation of continuous
CFEs. However, it remains unclear whether these cycle
length changes were observed incrementally or abruptly
during lesion creation in speciﬁc locations. From these
observations, the investigators conclude that LA DE
abnormalities observed using high-resolution CMR
imaging interact uniquely with CFE abnormalities during
persistent and long-standing persistent AF. They further
conclude that sites manifesting DE and CFE abnormalities
have mechanistic implications and so may be more prom-
ising ablation targets.
So how should we interpret these interesting data? First
and foremost, by demonstrating LA scarring using the same
CMR imaging sequence that was originally described by
Oakes et al. (5), these investigators have validated the
reproducibility of this particular imaging technique for
identifying atrial DE abnormalities in patients with AF.
There are, however, some noteworthy differences in the DE
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814distribution between the 2 studies. In the current study, DE
was predominantly conﬁned to the posterior LA, whereas in
the Oakes et al. series, this was more widespread (including
the septum and anterior LA wall). Also, the dense DE
distribution noted in the current study (near the posterior
aspect of the left PVs) is unique. There are a few possible
explanations for these discrepancies. The investigators in
the current study used slice-based voxel intensities at 4
SD compared with the Oakes et al. series, which used “an
experienced observer to choose threshold levels” based on 2,
3, or 4 SD. This modiﬁcation in the current study was made
to improve speciﬁcity. However, it is not clear that this
assumption is true because DE abnormalities at lower SDs
are not reported or compared. Also, CMR sequences in the
current study were acquired during AF, whereas in the
Oakes et al. series, the majority (>90%) of acquisitions were
during sinus rhythm. It is also important to note that the
resolution limit of DE imaging is w1 mm. Thus, DE
abnormalities in the LA, especially in the posterior wall,
which in some patients/locations is only 3 to 5 mm thick (7)
may artiﬁcially appear patchy. One way to exclude this
possibility would be to compare DE abnormalities to
bipolar voltage distribution in these areas. However, because
the LA chamber in this series was created during AF (which
can signiﬁcantly attenuate signal amplitude), it is impossible
to accurately characterize voltage abnormalities (1,2).
Presuming that the LA DE distribution, especially the
dense patches around the left PVs, was indeed from ﬁbrotic
scars, did this translate into reduced radiofrequency energy/
lesions in these locations during left PVI? Could there be
another explanation for the distribution of dense DE in this
location? The authors suggest that this location is in close
proximity to the descending aorta, and the ﬁbrotic changes
observed may be due to higher shear force. If so, this would
imply that these DE abnormalities are not speciﬁc to
patients with AF. However, the lack of a control group in
this study precludes that determination. Interestingly,
a control group was used in the study by Oakes et al. (5),
and no DE abnormalities were seen in those subjects.
Another limitation of DE data in the current study pertains
to the manual contouring technique that was used to
demarcate DE regions: in the examples shown, the
boundaries for regions manifesting patchy and dense DE do
not conform to standard anatomic LA segments. Despite
this limitation, the CFE distribution vis-à-vis DE abnor-
malities, as observed in this series, is intriguing. Contrary to
the investigators’ hypothesis, continuous CFEs and frac-
tionated EGMs were more commonly noted at LA sites
manifesting patchy or no DE abnormalities. Within the
dense DE areas, CFEs were lacking and EGM content was
organized and slower. Nevertheless, the AF cycle length in
patients with higher overall DE content was signiﬁcantly
shorter. These 2 observations seem counterintuitive. If
indeed dense DE manifested more organized and slower
EGM content, why should the AF be faster in atria man-
ifesting higher DE content? One possible explanation forthis discrepancy is that CFEs during AF are an “epi”
phenomenon. Studies have shown that CFE generation can
occur in a variety of scenarios (e.g., ﬁbrillatory conduction,
wavelet breaks, conduction blocks, far-ﬁeld signals), few of
which actually involve AF sources (8–10). Although ﬁbrosis
may cause CFE formation (by promoting conduction blocks
or wave breaks, for example), its presence is not a prereq-
uisite (11). Tissue anisotropy and functional blocks without
ﬁbrosis can also result in CFEs (12). The ﬁndings of this
study certainly bear this out (CFEs were equally observed in
locations manifesting patchy or no DE abnormalities). In
addition to analyzing CFE distribution, the authors
attempted to meticulously characterize organization during
AF at locations manifesting different DE abnormalities. It
should, however, be pointed out that manual assessment of
isolated bipolar EGM recordings acquired during manip-
ulation of a multipolar catheter in LA is less than ideal for
demonstrating organization during AF (13). Therefore, the
inverse interaction between severity of DE abnormality and
CFE distribution observed in this study, whereas novel,
remains mechanistically unexplained. The authors contend
that sites manifesting DE and CFE abnormalities may be
more promising ablation targets. However, this conclusion
is not supported by data because the ablation strategy used
in this study was not based on DE distribution. In that
context, it is worth noting that in previous studies, the
presence of LA scar was associated with worse outcomes
after standard AF ablation (5,14).
Despite these limitations, this study is an important step
in correlating DE abnormalities with the electrophysiology
of the underlying substrate in patients with persistent and
long-standing persistent AF. To further explore this asso-
ciation, it may be worthwhile to corroborate DE abnor-
malities with LA bipolar voltage distribution, similar to what
has been accomplished in the ventricles (15). However,
currently there are no well-deﬁned voltage criteria to char-
acterize LA scar. Perhaps the information obtained from
DE CMR imaging can help us develop voltage cutoffs that
may identify substrate abnormalities in the same distribution
as the DE abnormalities. This combination may also allow
for more erudite targeting of the underlying substrate in
patients with persistent AF. Certainly based on the ﬁndings
of the current study, a prospective trial can be designed that
compares standard AF ablation strategy to one that incor-
porates additional ablation at sites manifesting DE abnor-
malities. If such a trial shows signiﬁcantly improved
outcomes in the group in which DE abnormalities were also
ablated, then perhaps we may be able to say with more
conviction that these sites are promising ablation targets in
patients with persistent AF.
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